Cargando…

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage

BACKGROUND: Amotosalen/UVA pathogen‐reduced platelet components (PRPCs) with storage up to 7 days are standard of care in France, Switzerland, and Austria. PRPCs provide effective hemostasis with reduced risk of transfusion‐transmitted infections and transfusion‐associated graft versus host disease,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cancelas, Jose A., Genthe, Jamie R., Stolla, Moritz, Rugg, Neeta, Bailey, S. Lawrence, Nestheide, Shawnagay, Shaz, Beth, Mack, Samantha, Schroeder, Kadi, Anani, Waseem, Szczepiorkowski, Zbigniew M., Dumont, Larry J., Yegneswaran, Subramanian, Corash, Laurence, Mufti, Nina, Benjamin, Richard J., Erickson, Anna C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Blood Components
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546462/ https://www.ncbi.nlm.nih.gov/pubmed/35808974 http://dx.doi.org/10.1111/trf.17003

Ejemplares similares

Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma
por: Cancelas, Jose A., et al.
Publicado: (2021)

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
por: North, Anne K., et al.
Publicado: (2020)

Prolonged (post‐thaw) shelf life of −80°C frozen AB apheresis plasma
por: Rijnhout, Tim W.H., et al.
Publicado: (2020)

The quality of stored umbilical cord and adult-donated whole blood in Mombasa, Kenya
por: Hassall, Oliver, et al.
Publicado: (2010)

Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
por: Feussner, Annette, et al.
Publicado: (2014)

Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects
por: Rosskopf, Konrad, et al.
Publicado: (2020)

The use of cryopreserved platelets in a trauma‐induced hemorrhage model
por: Kleinveld, Derek J.B., et al.
Publicado: (2020)

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
por: Shebl, Amgad, et al.
Publicado: (2020)

Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020)

Impact of cold storage on platelets treated with Intercept pathogen inactivation
por: Six, Katrijn R., et al.
Publicado: (2019)

Evaluation of riboflavin photochemical treatment for inactivation of HCT116 tumor cells mixed in simulative intraoperative salvage blood
por: Yu, Yang, et al.
Publicado: (2019)

Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system
por: de Bruin, Sanne, et al.
Publicado: (2019)

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
por: Delabie, Willem, et al.
Publicado: (2019)

The use of a hematology analyzer with a new generation of software as an alternative to flow cytometry for enumerating residual white blood cells in blood components
por: Blanco, Richard Alejo, et al.
Publicado: (2019)

Effective inactivation of a wide range of viruses by pasteurization
por: Gröner, Albrecht, et al.
Publicado: (2017)

Residual red cells in blood components: A multisite study of fully automated enumeration using a hematology analyzer
por: Cavagnetto, Chloe, et al.
Publicado: (2020)

Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols
por: Tynngård, Nahreen, et al.
Publicado: (2020)

Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
por: Roth, Nathan J., et al.
Publicado: (2020)

Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?
por: Wendel, Silvano, et al.
Publicado: (2021)

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
por: Sow, Cissé, et al.
Publicado: (2022)

Frozen and freeze‐dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality
por: Heger, Andrea, et al.
Publicado: (2022)

Frozen for combat: Quality of deep‐frozen thrombocytes, produced and used by The Netherlands Armed Forces 2001–2021
por: Noorman, Femke, et al.
Publicado: (2022)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Associations of blood pressure components with risks of cardiovascular events and all‐cause death in a Chinese population: A Prospective Study
por: Zhang, Zhongying, et al.
Publicado: (2022)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light
por: Infanti, Laura, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations
por: Laub, R, et al.
Publicado: (2010)

In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations
por: Dhainaut, F, et al.
Publicado: (2013)

Defining and measuring blood donor altruism: a theoretical approach from biology, economics and psychology
por: Evans, R, et al.
Publicado: (2014)

Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors
por: Rosa-Bray, M, et al.
Publicado: (2013)

The effect of plasmapheresis on blood pressure in voluntary plasma donors
por: Rosa-Bray, M, et al.
Publicado: (2015)

Perspectives on the impact of storage duration on blood quality and transfusion outcomes
por: Roback, J. D.
Publicado: (2016)

Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time
por: Garner, S. F., et al.
Publicado: (2016)

Donor InSight: characteristics and representativeness of a Dutch cohort study on blood and plasma donors
por: Timmer, Tiffany C., et al.
Publicado: (2018)

Red‐blood‐cell manufacturing methods and storage solutions differentially induce pulmonary cell activation
por: Wirtz, Mathijs R., et al.
Publicado: (2020)

The supply chain of migrant blood donors: an organisational interview study
por: Klinkenberg, Elisabeth F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lfrplcj54uapjbnp5e9659bve1